TTK Healthcare Limited — Board Meeting, 21-03-2025: Outcome of Board Meeting

The Board of Directors has approved the redesignation of Mr. S Kalyanaraman from Wholetime Director & CEO to Managing Director & CEO, effective immediately until May 31, 2029, pending shareholder approval via Postal Ballot. The Board has also approved the draft Notice for the Postal Ballot and appointed M/s A K Jain & Associates as Scrutinizer. This process will facilitate remote e-Voting for the shareholder decision. Further details on the Calendar of Events for the Postal Ballot process have been shared as well.